APO RESEARCH · REPORT
Peanut Allergy Therapeutics
Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.
Product & engineering
Understand the product.
Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.
Selected research
Market Structure
Global Peanut Allergy Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.
United States is the largest consumption place, with a consumption market share nearly 45% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Mylan, Bayer, UCB Pharma, J & J, Perrigo,top 5 players took 52% market share.
Read the full market overview
Report Includes
This report provides an overview of the global Peanut Allergy Therapeutics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Peanut Allergy Therapeutics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Peanut Allergy Therapeutics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Peanut Allergy Therapeutics market size, projected growth trends, production technologies, key applications, and end-use industries.
Peanut Allergy Therapeutics Segment by Company
Mylan
Bayer
UCB Pharma
J & J
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
HUAPONT Pharm
Allergy Therapeutics
ASIT Biotech
Sanofi
DBV Technologies
HAL Allergy
Intrommune Therapeutics
Peanut Allergy Therapeutics Segment by Type
Epinephrine Injection
Antihistamines
Oral Immunotherapy
Other
Peanut Allergy Therapeutics Segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Other
Peanut Allergy Therapeutics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peanut Allergy Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peanut Allergy Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peanut Allergy Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Peanut Allergy Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Peanut Allergy Therapeutics industry.
Chapter 3: Detailed analysis of Peanut Allergy Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peanut Allergy Therapeuticsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Epinephrine Injection
- Antihistamines
- Oral Immunotherapy
- Other
Applications
- Hospital Pharmacy
- Retail Pharmacy
- Other
Companies covered
- Mylan
- Bayer
- UCB Pharma
- J & J
- Perrigo
- GSK
- Kaleo
- Amneal Pharma
- ALK Abello
- Aimmune Therapeutics
- HUAPONT Pharm
- Allergy Therapeutics
- ASIT Biotech
- Sanofi
- DBV Technologies
- HAL Allergy
- Intrommune Therapeutics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Peanut Allergy Therapeutics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Epinephrine Injection
- 1.2.3 Antihistamines
- 1.2.4 Oral Immunotherapy
- 1.2.5 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Peanut Allergy Therapeutics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital Pharmacy
- 1.3.3 Retail Pharmacy
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Peanut Allergy Therapeutics Growth Trends by Region
- 1.5.1 Global Peanut Allergy Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Peanut Allergy Therapeutics Market Size by Region (2021-2026)
- 1.5.3 Peanut Allergy Therapeutics Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Peanut Allergy Therapeutics Market Dynamics
- 2.1 Peanut Allergy Therapeutics Industry Trends
- 2.2 Peanut Allergy Therapeutics Industry Drivers
- 2.3 Peanut Allergy Therapeutics Industry Opportunities and Challenges
- 2.4 Peanut Allergy Therapeutics Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Peanut Allergy Therapeutics Revenue by Company (2021-2026)
- 3.2 Global Peanut Allergy Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Peanut Allergy Therapeutics Key Company Head office and Area Served
- 3.4 Global Peanut Allergy Therapeutics Company, Product Type & Application
- 3.5 Global Peanut Allergy Therapeutics Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Peanut Allergy Therapeutics Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Peanut Allergy Therapeutics Players Market Share by Revenue in 2025
- 3.6.3 2025 Peanut Allergy Therapeutics Tier 1, Tier 2, and Tier 3
4 Peanut Allergy Therapeutics Market by Type
- 4.1 Global Peanut Allergy Therapeutics Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Peanut Allergy Therapeutics Market Size by Type (2021-2032)
- 4.3 Global Peanut Allergy Therapeutics Market Size Share by Type (2021-2032)
5 Peanut Allergy Therapeutics Market by Application
- 5.1 Global Peanut Allergy Therapeutics Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Peanut Allergy Therapeutics Market Size by Application (2021-2032)
- 5.3 Global Peanut Allergy Therapeutics Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Mylan
- 6.1.1 Mylan Company Information
- 6.1.2 Mylan Business Overview
- 6.1.3 Mylan Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Mylan Peanut Allergy Therapeutics Product Portfolio
- 6.1.5 Mylan Recent Developments
- 6.2 Bayer
- 6.2.1 Bayer Company Information
- 6.2.2 Bayer Business Overview
- 6.2.3 Bayer Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Bayer Peanut Allergy Therapeutics Product Portfolio
- 6.2.5 Bayer Recent Developments
- 6.3 UCB Pharma
- 6.3.1 UCB Pharma Company Information
- 6.3.2 UCB Pharma Business Overview
- 6.3.3 UCB Pharma Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 UCB Pharma Peanut Allergy Therapeutics Product Portfolio
- 6.3.5 UCB Pharma Recent Developments
- 6.4 J & J
- 6.4.1 J & J Company Information
- 6.4.2 J & J Business Overview
- 6.4.3 J & J Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 J & J Peanut Allergy Therapeutics Product Portfolio
- 6.4.5 J & J Recent Developments
- 6.5 Perrigo
- 6.5.1 Perrigo Company Information
- 6.5.2 Perrigo Business Overview
- 6.5.3 Perrigo Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Perrigo Peanut Allergy Therapeutics Product Portfolio
- 6.5.5 Perrigo Recent Developments
- 6.6 GSK
- 6.6.1 GSK Company Information
- 6.6.2 GSK Business Overview
- 6.6.3 GSK Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 GSK Peanut Allergy Therapeutics Product Portfolio
- 6.6.5 GSK Recent Developments
- 6.7 Kaleo
- 6.7.1 Kaleo Company Information
- 6.7.2 Kaleo Business Overview
- 6.7.3 Kaleo Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Kaleo Peanut Allergy Therapeutics Product Portfolio
- 6.7.5 Kaleo Recent Developments
- 6.8 Amneal Pharma
- 6.8.1 Amneal Pharma Company Information
- 6.8.2 Amneal Pharma Business Overview
- 6.8.3 Amneal Pharma Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Amneal Pharma Peanut Allergy Therapeutics Product Portfolio
- 6.8.5 Amneal Pharma Recent Developments
- 6.9 ALK Abello
- 6.9.1 ALK Abello Company Information
- 6.9.2 ALK Abello Business Overview
- 6.9.3 ALK Abello Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 ALK Abello Peanut Allergy Therapeutics Product Portfolio
- 6.9.5 ALK Abello Recent Developments
- 6.10 Aimmune Therapeutics
- 6.10.1 Aimmune Therapeutics Company Information
- 6.10.2 Aimmune Therapeutics Business Overview
- 6.10.3 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Aimmune Therapeutics Peanut Allergy Therapeutics Product Portfolio
- 6.10.5 Aimmune Therapeutics Recent Developments
- 6.11 HUAPONT Pharm
- 6.11.1 HUAPONT Pharm Company Information
- 6.11.2 HUAPONT Pharm Business Overview
- 6.11.3 HUAPONT Pharm Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 HUAPONT Pharm Peanut Allergy Therapeutics Product Portfolio
- 6.11.5 HUAPONT Pharm Recent Developments
- 6.12 Allergy Therapeutics
- 6.12.1 Allergy Therapeutics Company Information
- 6.12.2 Allergy Therapeutics Business Overview
- 6.12.3 Allergy Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Allergy Therapeutics Peanut Allergy Therapeutics Product Portfolio
- 6.12.5 Allergy Therapeutics Recent Developments
- 6.13 ASIT Biotech
- 6.13.1 ASIT Biotech Company Information
- 6.13.2 ASIT Biotech Business Overview
- 6.13.3 ASIT Biotech Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 ASIT Biotech Peanut Allergy Therapeutics Product Portfolio
- 6.13.5 ASIT Biotech Recent Developments
- 6.14 Sanofi
- 6.14.1 Sanofi Company Information
- 6.14.2 Sanofi Business Overview
- 6.14.3 Sanofi Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Sanofi Peanut Allergy Therapeutics Product Portfolio
- 6.14.5 Sanofi Recent Developments
- 6.15 DBV Technologies
- 6.15.1 DBV Technologies Company Information
- 6.15.2 DBV Technologies Business Overview
- 6.15.3 DBV Technologies Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 DBV Technologies Peanut Allergy Therapeutics Product Portfolio
- 6.15.5 DBV Technologies Recent Developments
- 6.16 HAL Allergy
- 6.16.1 HAL Allergy Company Information
- 6.16.2 HAL Allergy Business Overview
- 6.16.3 HAL Allergy Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 HAL Allergy Peanut Allergy Therapeutics Product Portfolio
- 6.16.5 HAL Allergy Recent Developments
- 6.17 Intrommune Therapeutics
- 6.17.1 Intrommune Therapeutics Company Information
- 6.17.2 Intrommune Therapeutics Business Overview
- 6.17.3 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Intrommune Therapeutics Peanut Allergy Therapeutics Product Portfolio
- 6.17.5 Intrommune Therapeutics Recent Developments
7 North America
- 7.1 North America Peanut Allergy Therapeutics Market Size (2021-2032)
- 7.2 North America Peanut Allergy Therapeutics Market Size by Type
- 7.2.1 North America Peanut Allergy Therapeutics Market Size by Type (2021-2026)
- 7.2.2 North America Peanut Allergy Therapeutics Market Size by Type (2027-2032)
- 7.2.3 North America Peanut Allergy Therapeutics Market Share by Type (2021-2032)
- 7.3 North America Peanut Allergy Therapeutics Market Size by Application
- 7.3.1 North America Peanut Allergy Therapeutics Market Size by Application (2021-2026)
- 7.3.2 North America Peanut Allergy Therapeutics Market Size by Application (2027-2032)
- 7.3.3 North America Peanut Allergy Therapeutics Market Share by Application (2021-2032)
- 7.4 North America Peanut Allergy Therapeutics Market Size by Country
- 7.4.1 North America Peanut Allergy Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Peanut Allergy Therapeutics Market Size by Country (2021-2026)
- 7.4.3 North America Peanut Allergy Therapeutics Market Size by Country (2027-2032)
- 7.4.4 North America Peanut Allergy Therapeutics Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Peanut Allergy Therapeutics Market Size (2021-2032)
- 8.2 Europe Peanut Allergy Therapeutics Market Size by Type
- 8.2.1 Europe Peanut Allergy Therapeutics Market Size by Type (2021-2026)
- 8.2.2 Europe Peanut Allergy Therapeutics Market Size by Type (2027-2032)
- 8.2.3 Europe Peanut Allergy Therapeutics Market Share by Type (2021-2032)
- 8.3 Europe Peanut Allergy Therapeutics Market Size by Application
- 8.3.1 Europe Peanut Allergy Therapeutics Market Size by Application (2021-2026)
- 8.3.2 Europe Peanut Allergy Therapeutics Market Size by Application (2027-2032)
- 8.3.3 Europe Peanut Allergy Therapeutics Market Share by Application (2021-2032)
- 8.4 Europe Peanut Allergy Therapeutics Market Size by Country
- 8.4.1 Europe Peanut Allergy Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Peanut Allergy Therapeutics Market Size by Country (2021-2026)
- 8.4.3 Europe Peanut Allergy Therapeutics Market Size by Country (2027-2032)
- 8.4.4 Europe Peanut Allergy Therapeutics Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Peanut Allergy Therapeutics Market Size (2021-2032)
- 9.2 China Peanut Allergy Therapeutics Market Size by Type
- 9.2.1 China Peanut Allergy Therapeutics Market Size by Type (2021-2026)
- 9.2.2 China Peanut Allergy Therapeutics Market Size by Type (2027-2032)
- 9.2.3 China Peanut Allergy Therapeutics Market Share by Type (2021-2032)
- 9.3 China Peanut Allergy Therapeutics Market Size by Application
- 9.3.1 China Peanut Allergy Therapeutics Market Size by Application (2021-2026)
- 9.3.2 China Peanut Allergy Therapeutics Market Size by Application (2027-2032)
- 9.3.3 China Peanut Allergy Therapeutics Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Peanut Allergy Therapeutics Market Size (2021-2032)
- 10.2 Asia Peanut Allergy Therapeutics Market Size by Type
- 10.2.1 Asia Peanut Allergy Therapeutics Market Size by Type (2021-2026)
- 10.2.2 Asia Peanut Allergy Therapeutics Market Size by Type (2027-2032)
- 10.2.3 Asia Peanut Allergy Therapeutics Market Share by Type (2021-2032)
- 10.3 Asia Peanut Allergy Therapeutics Market Size by Application
- 10.3.1 Asia Peanut Allergy Therapeutics Market Size by Application (2021-2026)
- 10.3.2 Asia Peanut Allergy Therapeutics Market Size by Application (2027-2032)
- 10.3.3 Asia Peanut Allergy Therapeutics Market Share by Application (2021-2032)
- 10.4 Asia Peanut Allergy Therapeutics Market Size by Country
- 10.4.1 Asia Peanut Allergy Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Peanut Allergy Therapeutics Market Size by Country (2021-2026)
- 10.4.3 Asia Peanut Allergy Therapeutics Market Size by Country (2027-2032)
- 10.4.4 Asia Peanut Allergy Therapeutics Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Peanut Allergy Therapeutics Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Peanut Allergy Therapeutics Market Size by Type
- 11.2.1 South America, Middle East & Africa Peanut Allergy Therapeutics Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Peanut Allergy Therapeutics Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Peanut Allergy Therapeutics Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Peanut Allergy Therapeutics Market Size by Application
- 11.3.1 South America, Middle East & Africa Peanut Allergy Therapeutics Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Peanut Allergy Therapeutics Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Peanut Allergy Therapeutics Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Peanut Allergy Therapeutics Market Size by Country
- 11.4.1 South America, Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Peanut Allergy Therapeutics Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst